Viewing Study NCT04818320


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-05-15 @ 3:43 PM
Study NCT ID: NCT04818320
Status: COMPLETED
Last Update Posted: 2021-11-24
First Post: 2021-03-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Favipiravir in High-risk COVID-19 Patients
Sponsor: Penang Hospital, Malaysia
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: Favirpiravir-A1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View
None UNKNOWN View
None OTHER_GOV View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None OTHER_GOV View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None UNKNOWN View